🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
336

Quick answer

United Therapeutics Europe has 336 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Axitinib

    United Therapeutics Europe Ltd

    Clear-cell Metastatic Renal Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  2. B-CIT and SPECT imaging

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 small molecule completed

    1 trial

  3. Beclometasone

    United Therapeutics Europe Ltd

    Asthma

    phase 2 small molecule completed

    1 trial

  4. Bemarituzumab + Flot regimen

    United Therapeutics Europe Ltd

    Gastric and Gastro-oesophageal Junction (GEJ) Adenocarcinomas

    phase 2 small molecule terminated

    1 trial

  5. Bevacizumab

    United Therapeutics Europe Ltd

    Recurrent Glioblastoma

    phase 2 mab active

    1 trial

  6. Bevacizumab

    United Therapeutics Europe Ltd

    Metastatic Melanoma

    phase 2 mab completed

    1 trial

  7. Bevacizumab

    United Therapeutics Europe Ltd

    Colorectal Adenocarcinoma

    phase 2 mab completed

    1 trial

  8. Binimetinib

    United Therapeutics Europe Ltd

    Locally Advanced Pancreatic Carcinoma

    phase 2 small molecule terminated

    1 trial

  9. Binimetinib

    United Therapeutics Europe Ltd

    Metastatic Colorectal Carcinoma

    phase 2 small molecule completed

    1 trial

  10. BoNT A

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  11. Brentuximab Vedotin

    United Therapeutics Europe Ltd

    Ann Arbor Stage IB Hodgkin Lymphoma

    phase 2 small molecule active

    1 trial

  12. CT-011

    United Therapeutics Europe Ltd

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  13. CYD Dengue Vaccine

    United Therapeutics Europe Ltd

    Dengue

    phase 2 mab completed

    1 trial

  14. Calcium Gluconate

    United Therapeutics Europe Ltd

    Trauma

    phase 2 small molecule active

    1 trial

  15. Camostat Mesilate

    United Therapeutics Europe Ltd

    Severe Acute Respiratory Syndrome

    phase 2 small molecule completed

    1 trial

  16. Carboplatin

    United Therapeutics Europe Ltd

    Recurrent Fallopian Tube Carcinoma

    phase 2 small molecule active

    1 trial

  17. Carboplatin

    United Therapeutics Europe Ltd

    Hormone Refractory Prostate Cancer

    phase 2 small molecule active

    1 trial

  18. Carboplatin plus Paclitaxel

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  19. Cediranib

    United Therapeutics Europe Ltd

    Alveolar Soft-part Sarcoma

    phase 2 small molecule active

    1 trial

  20. Celecoxib

    United Therapeutics Europe Ltd

    Head and Neck Cancer

    phase 2 small molecule terminated

    1 trial

  21. Ceralasertib

    United Therapeutics Europe Ltd

    Gynaecological Cancers

    phase 2 small molecule active

    1 trial

  22. Cetuximab

    United Therapeutics Europe Ltd

    BRAF V600E Negative

    phase 2 mab active

    1 trial

  23. Ciclosporin

    United Therapeutics Europe Ltd

    Myocardial Reperfusion Injury

    phase 2 small molecule completed

    1 trial

  24. Ciprofloxacin

    United Therapeutics Europe Ltd

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  25. Clobetasol Propionate

    United Therapeutics Europe Ltd

    Colon Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  26. Coenzyme Q10

    United Therapeutics Europe Ltd

    Charcot Marie Tooth Disease

    phase 2 small molecule completed

    1 trial

  27. Cold Stored Platelets (CSP)

    United Therapeutics Europe Ltd

    Trauma

    phase 2 mab completed

    1 trial

  28. Cold stored platelets in 100% plasma stored for 10-14 days

    United Therapeutics Europe Ltd

    Hemorrhage

    phase 2 mab active

    1 trial

  29. Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)

    United Therapeutics Europe Ltd

    Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  30. Concord grape juice

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 2 other completed

    1 trial

  31. Convalescent Plasma

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 mab terminated

    1 trial

  32. Cyclophosphamide

    United Therapeutics Europe Ltd

    Metastatic Melanoma

    phase 2 small molecule terminated

    1 trial

  33. Cytovir-ADV

    United Therapeutics Europe Ltd

    ADV Infection Post Allo-HSCT

    phase 2 mab completed

    1 trial

  34. DC1 Vaccine

    United Therapeutics Europe Ltd

    Breast Cancer Female

    phase 2 mab active

    1 trial

  35. DESTRESS-PC

    United Therapeutics Europe Ltd

    Posttraumatic Stress Disorder (PTSD)

    phase 2 other completed

    1 trial

  36. DNA vaccine prime

    United Therapeutics Europe Ltd

    Malaria

    phase 2 mab completed

    1 trial

  37. Dendritic Cell/Tumor Fusion Vaccine

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 mab terminated

    1 trial

  38. Desmopressin Injection

    United Therapeutics Europe Ltd

    Stroke, Acute

    phase 2 small molecule completed

    1 trial

  39. Dexamethasone

    United Therapeutics Europe Ltd

    Voice Change

    phase 2 small molecule active

    1 trial

  40. Dinutuximab

    United Therapeutics Europe Ltd

    Ganglioneuroblastoma

    phase 2 mab completed

    1 trial

  41. Doxazosin Mesylate, Extended Release

    United Therapeutics Europe Ltd

    Stress Disorders, Post-Traumatic

    phase 2 small molecule active

    1 trial

  42. Doxycycline

    United Therapeutics Europe Ltd

    Advanced Malignant Neoplasm

    phase 2 small molecule completed

    1 trial

  43. Drug COVID19-0001-USR

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 2 small molecule active

    1 trial

  44. Durvalumab

    United Therapeutics Europe Ltd

    Stage IB Hepatocellular Carcinoma AJCC v8

    phase 2 mab active

    1 trial

  45. E. coli ETVAX

    United Therapeutics Europe Ltd

    Diarrhea

    phase 2 mab completed

    1 trial

  46. Elliptical exercise

    United Therapeutics Europe Ltd

    Adult

    phase 2 other completed

    1 trial

  47. Enfortumab vedotin

    United Therapeutics Europe Ltd

    Metastatic Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  48. Enzalutamide 40mg

    United Therapeutics Europe Ltd

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

336 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.